Rogletimide: Difference between revisions
No edit summary |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
{{Short description|A drug that was investigated for its potential effects on sleep disorders}} | |||
'''Rogletimide''' | '''Rogletimide''' is a pharmaceutical compound that was investigated for its potential use in the treatment of [[sleep disorders]]. It is a derivative of the drug [[glutethimide]], which is a sedative and hypnotic medication. Rogletimide was studied primarily for its effects on the [[endocrine system]], particularly its ability to influence the secretion of [[melatonin]], a hormone that regulates sleep-wake cycles. | ||
== | ==Pharmacology== | ||
Rogletimide is classified as a [[melatonin receptor antagonist]]. It works by blocking the action of melatonin at its receptors, which are primarily located in the [[suprachiasmatic nucleus]] of the [[hypothalamus]]. This region of the brain is responsible for controlling circadian rhythms, including the sleep-wake cycle. | |||
[[ | The drug was hypothesized to alter the natural production and release of melatonin, thereby affecting sleep patterns. By antagonizing melatonin receptors, rogletimide was thought to potentially reset or adjust the circadian clock, making it a candidate for treating disorders such as [[insomnia]] and [[jet lag]]. | ||
[[ | |||
==Clinical Research== | |||
Although rogletimide showed promise in preclinical studies, its development was not pursued to the point of widespread clinical use. Initial trials focused on its ability to modulate melatonin levels and its potential effects on sleep architecture. However, the results were not sufficiently compelling to warrant further development, and the drug did not progress beyond early-stage clinical trials. | |||
==Potential Applications== | |||
Despite its limited development, rogletimide's mechanism of action provides insight into the role of melatonin in sleep regulation. Understanding how melatonin receptor antagonists like rogletimide can influence sleep may inform future research into treatments for sleep disorders. | |||
==Related Compounds== | |||
Rogletimide is chemically related to [[glutethimide]], a sedative that was once used to treat [[insomnia]] but has largely been replaced by newer medications with improved safety profiles. Other melatonin receptor antagonists and agonists continue to be explored for their potential therapeutic benefits in sleep medicine. | |||
==See also== | |||
* [[Melatonin]] | |||
* [[Circadian rhythm]] | |||
* [[Sleep disorder]] | |||
* [[Glutethimide]] | |||
==Related pages== | |||
* [[Insomnia]] | |||
* [[Jet lag]] | |||
* [[Endocrine system]] | |||
[[Category:Sedatives]] | |||
[[Category:Hypnotics]] | |||
[[Category:Melatonin receptor antagonists]] | |||
Latest revision as of 19:16, 22 March 2025
A drug that was investigated for its potential effects on sleep disorders
Rogletimide is a pharmaceutical compound that was investigated for its potential use in the treatment of sleep disorders. It is a derivative of the drug glutethimide, which is a sedative and hypnotic medication. Rogletimide was studied primarily for its effects on the endocrine system, particularly its ability to influence the secretion of melatonin, a hormone that regulates sleep-wake cycles.
Pharmacology[edit]
Rogletimide is classified as a melatonin receptor antagonist. It works by blocking the action of melatonin at its receptors, which are primarily located in the suprachiasmatic nucleus of the hypothalamus. This region of the brain is responsible for controlling circadian rhythms, including the sleep-wake cycle.
The drug was hypothesized to alter the natural production and release of melatonin, thereby affecting sleep patterns. By antagonizing melatonin receptors, rogletimide was thought to potentially reset or adjust the circadian clock, making it a candidate for treating disorders such as insomnia and jet lag.
Clinical Research[edit]
Although rogletimide showed promise in preclinical studies, its development was not pursued to the point of widespread clinical use. Initial trials focused on its ability to modulate melatonin levels and its potential effects on sleep architecture. However, the results were not sufficiently compelling to warrant further development, and the drug did not progress beyond early-stage clinical trials.
Potential Applications[edit]
Despite its limited development, rogletimide's mechanism of action provides insight into the role of melatonin in sleep regulation. Understanding how melatonin receptor antagonists like rogletimide can influence sleep may inform future research into treatments for sleep disorders.
Related Compounds[edit]
Rogletimide is chemically related to glutethimide, a sedative that was once used to treat insomnia but has largely been replaced by newer medications with improved safety profiles. Other melatonin receptor antagonists and agonists continue to be explored for their potential therapeutic benefits in sleep medicine.
